Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4265)	5/7/1998 2:18:00 PM
From: Bhag Karamchandani	Read Replies (1) of 6136

'Why would the "insiders" want to buy more shares? ' If you accept that AGPH is a stable revenue producing commercial entity with a steady growth rate exceeding earnings multiples, then, as many on this thread have argued, AGPH is fundamentally undervalued. What better than for AGPH insiders to buy their company stock for the same reasons that dozens of insiders of other comapanies do; they see value and are confident about the future of their company. Just see the spate of insider buys( and sells)reported weekly in Barron's. You don't have to necessarily accept this argument if you don't wish to.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next